RBM39: A druggable metabolic sensor linking RNA splicing, transcriptional regulation, and metabolic reprogramming in cancer
Molecular Cell · 2023-12 · 83 (23) · 4202-4204
DOI: 10.1016/j.molcel.2023.11.012 ↗Kurz gefasst
Kommentar in der Zeitschrift Molecular Cell, 2023-12. Verfasst von Hector C Keun und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery & Cancer, Imperial College London, London, UK. Electronic address: h.keun@imperial.ac.uk. Hauptthemen laut MEDLINE: Neoplasms, RNA-Binding Proteins. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 10 Literaturangaben.
Abstract (Originalsprache)
In a recent issue of Cell, Mossmann et al.1 describe a novel role for an emerging cancer target, RNA-binding motif protein 39, as a metabolic sensor of the conditionally essential amino acid arginine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Surgery & Cancer, Imperial College London, London, UK. Electronic address: h.keun@imperial.ac.uk.
- Department of Surgery & Cancer, Imperial College London, London, UK.
Zitieren
APA
Keun, H. C., & Nijhuis, A. (2023). RBM39: A druggable metabolic sensor linking RNA splicing, transcriptional regulation, and metabolic reprogramming in cancer. Molecular Cell, 83(23), 4202-4204. https://doi.org/10.1016/j.molcel.2023.11.012
Vancouver
Keun HC, Nijhuis A. RBM39: A druggable metabolic sensor linking RNA splicing, transcriptional regulation, and metabolic reprogramming in cancer. Molecular Cell. 2023;83(23):4202-4204. doi:10.1016/j.molcel.2023.11.012
BibTeX
@article{Keun2023,
author = {Keun, Hector C and Nijhuis, Anke},
title = {RBM39: A druggable metabolic sensor linking RNA splicing, transcriptional regulation, and metabolic reprogramming in cancer},
journal = {Molecular Cell},
year = {2023},
volume = {83},
number = {23},
pages = {4202--4204},
doi = {10.1016/j.molcel.2023.11.012}
}
EUVIMED